CESSA logo

Cessatech A/S Stock Price

NGM:CESSA Community·DKK 313.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

CESSA Share Price Performance

DKK 16.90
8.65 (104.85%)
DKK 16.90
8.65 (104.85%)
Price DKK 16.90

CESSA Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with adequate balance sheet.

5 Risks
0 Rewards

Cessatech A/S Key Details

DKK 5.7m

Revenue

DKK 0

Cost of Revenue

DKK 5.7m

Gross Profit

DKK 16.6m

Other Expenses

-DKK 10.9m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-0.59
100.00%
-190.70%
0%
View Full Analysis

About CESSA

Founded
2020
Employees
3
CEO
Jes Trygved
WebsiteView website
www.cessatech.com

Cessatech A/S, a pivotal-stage pediatric biotech company, develops specialty hospital medicines for children in Denmark. Its lead candidate product is CT001, a fixed-dose nasal spray for treating acute pain in children. The company also develops CT002, a non-invasive intranasal sedation for children undergoing medical procedures in Phase 2 clinical trials; and CT003, a topical anesthetic in pre-clinical development. Cessatech A/S was incorporated in 2020 and is based in Copenhagen, Denmark.

Recent CESSA News & Updates

Recent updates

No updates